Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Comment by Newcastleon Oct 15, 2021 7:00am
288 Views
Post# 34008261

RE:RE:Cross Reactivity

RE:RE:Cross ReactivityI agree with Mr. Shediac. My daughter has Hon-Medical Science from Western. They want to make sure (because the test results accuracy is soooo good ... the Negative accuracy is 100%), that this test is not being affected by any other SARS pathogen besides Covid-19. Are you all aware that the CDC has stated that their goal is to eliminate the PCR test as the gold standard in favour of a Saliva Antigen test? The implications of this lab study are that Therma could rapidly become a key player in this space. Based on all factors I have learned thus far, this issue should have been eliminated long ago but was not in any data provided to the FDA by Therma. I am a large shareholder and abviously keen to see those results. The FDA has a moral responsibility to the public plus Ridge Global and the FDA would not be wasting their time on a flimsy solution. A private PCR Rapid Test is around C$150 - $199. If Therma can get to approval on the next home test phase with the Afero QR code enablement and price it around $20+ this product will go balistic.
<< Previous
Bullboard Posts
Next >>